Elisey A. Fedorov

Elisey A. Fedorov

Auto-generated profile, based on publicly available information

Elisey A. Fedorov

Saint Petersburg State University, Saint Petersburg State University Hospital

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Discover Oncology
Verified
Journal Article
Closed access
PDF file
LVL. I. Velikanova
L. I. Velikanova
ZSZ. R. Shafigullina
Z. R. Shafigullina
ALA. A. Lisitsin
A. A. Lisitsin
NVN. V. Vorokhobina
N. V. Vorokhobina
KGK. Grigoryan
K. Grigoryan
EBE. A. Bessonova
E. A. Bessonova

15 November 2021 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
DRD. V. Rebrova
D. V. Rebrova
NVN. V. Vorokhobina
N. V. Vorokhobina
EIEvgeny N. Imyanitov
Evgeny N. Imyanitov
ВРВ. Ф. Русаков
В. Ф. Русаков
LKL. M. Krasnov
L. M. Krasnov
JFJu. N Fedotov
Ju. N Fedotov
The widespread introduction of genetic testing in recent years has made it possible to determine that more than a third of cases of pheochromocytomas and paragangliomas (PPPGs) are caused by germline mutations. Despite the variety of catecholamine-producing tumors manifestations, there is a sufficient number of clinical and laboratory landmarks that suggest a hereditary genesis of the disease and even a specific syndrome. These include a family history, age of patient, presence of concomitant conditions, and symptoms of the disease. Considering that each of the mutations is associated with certain diseases that often determine tactics of treatment and examination of a patient, e.g. high risk of various malignancies. Awareness of the practitioner on the peculiarities of the course of family forms of PPPGs will allow improving the tactics of managing these patients.The article provides up-to-date information on the prevalence of hereditary PPPGs. The modern views on the pathogenesis of the disease induced by different mutations are presented. The main hereditary syndromes associated with PPPGs are described, including multiple endocrine neoplasia syndrome type 2A and 2B, type 1 neurofibromatosis, von Hippel-Lindau syndrome, hereditary paraganglioma syndrome, as well as clinical and laboratory features of the tumor in these conditions. The main positions on the necessity of genetic screening in patients with PPPGs are given.

25 April 2022 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
VRV. F. Rusakov
V. F. Rusakov
ISI. E. Shcherbakov
I. E. Shcherbakov
ICI. K. Chinchuk
I. K. Chinchuk
TST. V. Savelyeva
T. V. Savelyeva
DRD. V. Rebrova
D. V. Rebrova
EZE. A. Zgoda
E. A. Zgoda
BACKGROUND: In most cases adrenal tumours are detected by accident while performing medical imaging tests for other diseases. These findings are treated as adrenal incidentaloma. Prevalence of incidentalomas detected on CT scans is up to 4%. According to different authors, 4–12% of all adrenal tumours are adrenocortical carcinomas. As for today, the most significant medical imaging technique is CT scan with bolus IV injection of contrast agent and assessment of tumour’s density. The analysis of the results of CT imaging in 67 patients with ACC was carried out according to a single protocol. The main signs characteristic of this disease are described. It is very important to evaluate typical signs of ACC on CT scans for risk assessment of ACC before surgical treatment. If malignant tumour is suspected during preoperative examination, it is extremely important to choose the right surgical treatment strategy.AIM: To evaluate the significance of CT as the main method of preoperative diagnosis in patients with malignant tumors of the adrenal cortex. Studying CT semiotics of adrenocortical cancer in a large group of patients using a single standard imaging protocol. Find the main radiological symptoms characteristic of adrenocortical cancerMATERIALS AND METHODS: Here are the results of retrospective study of CT scans performed on 67 patients with adrenocortical carcinoma who received treatment in the Department of Endocrine Surgery of Saint-Petersburg State University N.I. Pirogov Clinic of High Medical Technologies during 2012–2020. The diagnostic significance of CT in patients with ACC was assessed.RESULTS: The most common features of ACC: tumour heterogeneity (84.3%), tumour’s size 3–9 cm (75%), signs of invasion into surrounding structures (10%), pre-contrast density above +30 HU (75%), absolute contrast washout less than 60% (68.8%), relative contrast washout less than 40% (64.6%)CONCLUSION: CT scan with IV contrast was not able to show any definitive pathognomonic signs of ACC. Nevertheless, CT scan should be performed in all patients with suspected (or confirmed using other medical imaging technique) adrenal tumour according to standard protocol. Bolus injection of contrast agent should be performed in all patients with tumour’s pre-contrast density above +5 HU.

11 November 2023 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
DRD. V. Rebrova
D. V. Rebrova
SGS. I. Grigorova
S. I. Grigorova
NVN. V. Vorokhobina
N. V. Vorokhobina
EZE. A. Zgoda
E. A. Zgoda
KNK. Yu. Novokshonov
K. Yu. Novokshonov
ISIlya Sleptsov
Ilya Sleptsov
A clinical case of a man 66 y.o. who was diagnosed with hormone-inactive pituitary macroadenoma complicated by corneal erosion and partial atrophy of the optic nerve of the left eye due to exophthalmos. The increase in prolactin level was regarded due to a «stalk-effect». The patient underwent a transnasal pituitary adenomectomy with subsequent regression of symptoms. After 4 years, against the background of a new coronavirus infection, increasing general weakness, headaches, a crisis increase in blood pressure and tachycardia attacks appeared. Computed tomography (CT) accidentally revealed an adrenal incidentaloma, in laboratory tests — hypercortisolism, elevated ACTH levels, hypokalemia, hyperglycemia, increased levels of metanephrine and normetanephrine. The patient developed acute steroid psychosis, after which an adrenalectomy with a tumor was performed, a pheochromocytoma was histologically confirmed. After surgery, there was a regression of symptoms, the development of adrenal insufficiency with reduced levels of ACTH and cortisol. Upon further examination, a polynodose euthyroid goiter was established, the biopsy of the nodes — Hashimoto’s thyroiditis (Bethesda II). Meanwhile, primary hyperparathyroidism was detected. According to ultrasound, scintigraphy with Ts99m-Technetril and CT revealed an increase of left parathyroid gland. A bilateral revision of the neck, removal of the right upper and left upper parathyroid adenomas were performed. In the postoperative period, the levels of calcium and parathyroid hormone were normalized. Given the presence of a combination of multiple tumors of the endocrine system (primary hyperparathyroidism, corticotropin-producing pheochromocytoma, hormone-inactive pituitary macroadenoma, polynodose euthyroid goiter), the MEN1 syndrome was clinically established. The study of 2 and 10 exons of the MEN1 gene revealed no mutations, which does not exclude the presence of a hereditary syndrome. The patient continues observation. In the available literature in Russian and English languages the case of ACTH pheochromocytoma as part of the MEN type 1 syndrome have not been found. Therefore, we consider the presented case to be the first one.

17 October 2022 in Langenbeck's Archives of Surgery
Verified
Journal Article
Closed access
PDF file
DBDmitrii M. Buzanakov
Dmitrii M. Buzanakov
ISIlya Sleptsov
Ilya Sleptsov
ASArseny Semenov
Arseny Semenov
RCRoman Анатольевич Chernikov
Roman Анатольевич Chernikov
KNKonstantin Y. Novokshonov
Konstantin Y. Novokshonov
ABAlexander N. Bubnov
Alexander N. Bubnov

1 January 2022 in Russian Journal of Anesthesiology and Reanimatology
Verified
Journal Article
Closed access
MAM.A. Alekseev
M.A. Alekseev
OKO.V. Kuleshov
O.V. Kuleshov
EFE.A. Fedorov
E.A. Fedorov
DRD.V. Rebrova
D.V. Rebrova
AKA.YU. Kulikov
A.YU. Kulikov
ICI.K. Chinchuk
I.K. Chinchuk
Анестезиологическое обеспечение операций по поводу удаления катехоламин-продуцирующих опухолей является вызовом для анестезиолога. Несмотря на значительное снижение смертности, сохраняется высокий уровень частоты периоперационных критических инцидентов и осложнений. В статье представлены методики, актуальные рекомендации и спорные вопросы предоперационной подготовки пациентов к оперативному лечению, в первую очередь, в отношении назначения блокаторов альфа-адренорецепторов на догоспитальном этапе. Освещены некоторые особенности применения хирургических доступов, аспектов периоперационного ведения, а также способов прогнозирования риска развития критических инцидентов. Частота выявления катехоламин-продуцирующих опухолей в популяции невысока, поэтому гарантией безопасности пациента в ходе оперативного лечения феохромоцитомы и параганглиомы является всесторонняя информированность и взаимодействие анестезиолого-хирургической бригады на каждом этапе ведения таких больных, начиная с догоспитального. Данный обзор представляет интерес для анестезиологов-реаниматологов, хирургов, терапевтов и эндокринологов, в практике которых катехоламин-продуцирующие опухоли могут встречаться рутинно или как исходно недиагностированная патология. Некоторые вопросы, связанные с периоперационным ведением пациентов с катехоламин-продуцирующими опухолями, остаются нерешенными и по-прежнему служат основанием для дальнейших исследований.